-

Cushman & Wakefield Arranges $71M Sale of Multifamily Property in Alabama

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK) announced that the commercial real estate services firm has arranged the sale of Colony Woods, a 414-unit multifamily property located in the Cahaba Heights submarket of Birmingham, Alabama. The final sale price was $71.4 million.

Cushman & Wakefield’s Andrew Brown and Craig Hey represented the seller, Forum Investment Group, in the transaction. The multifamily property was acquired by Arcan Capital.

“Colony Woods is a well-located asset in a high-traffic submarket of Birmingham just off Hwy 280. Surrounded by primarily Class A product, the property is well-positioned to benefit from a capital infusion campaign to upgrade unit interiors and amenities,” said Brown, Managing Director at Cushman & Wakefield. “Suburban Birmingham multifamily has also experienced recent rent growth at high occupancy levels and new ownership should be able to capitalize on the upside.”

Colony Woods was 96% leased at the time of sale. The multifamily property offers a prominent location for residents that provides close proximity to a variety of employment opportunities and retail.

Cushman & Wakefield’s Sunbelt Multifamily Advisory Group is a 95-person investment sales team covering 11 states with No. 1 multifamily market share in that region based on sales volume and transactions reported to CoStar. Per Cushman & Wakefield, in 2021, the group closed $13.8 billion in sales volume through 429 deals and nearly 85,000 units. For more information about the Sunbelt Multifamily Advisory Group, visit https://multifamily.cushwake.com.

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global real estate services firm that delivers exceptional value for real estate occupiers and owners. Cushman & Wakefield is among the largest real estate services firms with approximately 50,000 employees in over 400 offices and approximately 60 countries. In 2021, the firm had revenue of $9.4 billion across core services of property, facilities and project management, leasing, capital markets, and valuation and other services. To learn more, visit www.cushmanwakefield.com or follow @CushWake on Twitter.

Contacts

Jade Hubbard, Senior Communications Specialist
Jade.Hubbard@cushwake.com

Cushman & Wakefield

NYSE:CWK

Release Summary
Cushman & Wakefield arranged the $71.4 million sale of Colony Woods, a 414-unit multifamily property in Birmingham, Alabama.
Release Versions
Hashtags

Contacts

Jade Hubbard, Senior Communications Specialist
Jade.Hubbard@cushwake.com

More News From Cushman & Wakefield

Cushman & Wakefield: U.S. Legal Sector Leasing Hits Record 7.3 Million Square Feet in Q2 2026 as Law Firms Expand Footprints

NEW YORK--(BUSINESS WIRE)--U.S. legal sector leasing reached a quarterly record of 7.3 million square feet (sf) in the second quarter of 2026, surpassing the previous quarterly high by 23%, according to a new report from Cushman & Wakefield. First-half legal leasing reached nearly 12.2 million sf, up 17% year over year, as law firm demand continued to contribute to the recovery in U.S. office leasing. “The legal sector is showing a clear preference for larger footprints, with expansion acti...

Cushman & Wakefield Releases 2026 Data Center Development Cost Guide, Citing 21% Rise in Per-MW Construction Costs

NEW YORK--(BUSINESS WIRE)--Cushman & Wakefield (NYSE: CWK), a leading global commercial real estate services firm, has published its 2026 Data Center Development Cost Guide, revealing that data center construction costs have risen an average of 21% per megawatt (MW) since the previous edition was published in the fourth quarter of 2024. Covering markets across the United States and Canada, the guide provides a comprehensive overview of data center development economics spanning land acquisi...

Cushman & Wakefield: U.S. Life Sciences Market Moves Toward Rebalancing as Capital Returns and New Development Slows

NEW YORK--(BUSINESS WIRE)--The U.S. life sciences real estate sector is moving toward a gradual rebalancing as development activity contracts, investment sales recover and funding conditions strengthen, according to the latest Life Sciences Update from Cushman & Wakefield. While elevated vacancy and softer rents continue to weigh on near-term fundamentals, a reduced construction pipeline and improving demand indicators are positioning the market for healthier long-term growth. U.S. life sci...
Back to Newsroom